Ewing Sarcoma
Ewing sarcoma is a rare cancer that mostly affects children, teenagers and young adults. It is also one of the cancers where decades of research have produced a clear, well-tested treatment plan — and where most young people with localised disease are cured. This page will walk you through what it is and what comes next, in plain words for a frightening moment.
What Ewing sarcoma is — in plain words
Ewing sarcoma is a cancer that usually starts inside a bone, although in roughly one in four patients it begins in the soft tissue next to a bone instead. It was first described by an American pathologist, James Ewing, in 1921. For most of the twentieth century it was a feared diagnosis with poor outcomes. The story today is dramatically different.
What makes Ewing sarcoma unusual — and, in a way, easier to identify — is that almost every Ewing tumour carries the same specific genetic mistake. This is rare in cancer biology, and it is one of the reasons treatment has improved so much.
The molecular hallmark — the EWSR1-FLI1 fusion
Inside an Ewing sarcoma cell, two pieces of DNA that should never meet — one from chromosome 22 (the EWSR1 gene) and one from chromosome 11 (the FLI1 gene) — have broken and joined together. The resulting "fusion gene" produces an abnormal protein that drives the cancer.
This fusion is so characteristic that finding it in a biopsy sample is now part of how the diagnosis is confirmed. A small minority of Ewing-family tumours have a slightly different partner gene (most often ERG instead of FLI1), but the principle is the same. Your pathologist will arrange the molecular test on the biopsy tissue.
Who tends to get it
- Peak age 10 to 20. Most patients are children, teenagers or young adults. Ewing sarcoma is the second most common bone cancer in this age group, after osteosarcoma.
- Slightly more common in boys than in girls.
- Less common in older adults, although it can occur at any age.
Unlike many adult cancers, Ewing sarcoma is not linked to lifestyle, environment or family history in the vast majority of cases. It is not anybody's fault.
Where it usually shows up
Pelvis
One of the most common sites, and often the most difficult to operate on because of the surrounding nerves and blood vessels.
Long bones of the leg
The thigh bone (femur) and shin bone (tibia) are frequent sites.
Chest wall — ribs and scapula
A rib or shoulder blade tumour can grow inward into the chest, sometimes producing a fluid collection around the lung.
Spine
Less common but important — a spinal Ewing sarcoma can press on the spinal cord and needs urgent attention.
Arm
The humerus is another classic site.
Extraosseous (soft tissue) Ewing
In about a quarter of patients, the tumour starts in soft tissue next to bone rather than inside a bone. Treatment principles are the same.
The signs that should not be ignored
Bone pain
Often the first symptom. May be intermittent at first, then steadily worse. Pain that wakes a young person at night is particularly important.
Swelling or a lump
A firm, sometimes tender swelling over the affected bone, which may appear and then keep growing.
Fever, fatigue, weight loss
Unusually, Ewing sarcoma sometimes produces general symptoms that look like an infection. This can delay diagnosis when a child is treated for "bone infection" without imaging.
A fracture from minor trauma
The diseased bone is weaker than normal and can break under a stress it should have withstood.
Because the symptoms can look like a sports injury or a bone infection, Ewing sarcoma is sometimes diagnosed late. Persistent unexplained bone pain in a child or teenager deserves an X-ray — always.
"I tell every family the same thing on the first visit. Yes, this is one of the most demanding treatments we give. And yes, most young people with localised Ewing sarcoma walk out of this clinic, finish school, go to university, and get on with their lives. Both of those sentences are true at the same time."
How Ewing sarcoma is diagnosed
- Plain X-ray. Classic features include a "moth-eaten" or "onion-skin" appearance of the bone — layers of new bone formation around the tumour.
- MRI of the affected area. Defines the exact size and extent of the tumour, including any spread into the surrounding muscle. Essential for surgical planning.
- CT scan of the chest. The lungs are a common site of metastasis at diagnosis.
- PET-CT and bone scan. To look for spread to other bones and lymph nodes. Whole-body assessment is important because Ewing sarcoma can spread to multiple bones.
- Bone marrow biopsy. Sometimes performed to check for microscopic involvement of the marrow, particularly in younger patients.
- Biopsy with molecular testing. The diagnosis is confirmed on a tissue sample, with specific testing for the EWSR1 fusion. As with all sarcomas, the biopsy should be planned at a centre that will also do the eventual surgery.
How Ewing sarcoma is treated
Ewing sarcoma treatment is intensive and multimodal. Three things happen in sequence: chemotherapy, local control (surgery and/or radiation), then more chemotherapy. Total treatment is typically six to nine months. All three phases matter — none can be skipped without harming the outcome.
Phase 1 — Induction chemotherapy
Treatment begins with several months of intensive chemotherapy. The international standard regimen is called VDC/IE, in which two combinations are alternated every two weeks:
- VDC — vincristine, doxorubicin and cyclophosphamide.
- IE — ifosfamide and etoposide.
The goals of induction chemotherapy are to shrink the primary tumour, to kill any microscopic deposits that may already have spread, and to make local treatment safer and more effective. Read more about chemotherapy →
Phase 2 — Local control: surgery, radiation, or both
Once the tumour has shrunk, the team plans local treatment. The choice depends on the location, the response to chemotherapy, and the patient's age.
- Surgery is preferred when the tumour can be removed completely with a good margin of healthy tissue while preserving function. Limb-sparing techniques are used wherever possible.
- Radiation therapy is highly effective for Ewing sarcoma — far more so than for osteosarcoma. It is used when complete surgical removal is not possible (for example, in deep pelvic or spinal tumours), or in addition to surgery when the margins are close.
- Both are sometimes combined for the best local control.
Phase 3 — Consolidation chemotherapy
After local treatment, the remaining chemotherapy cycles are completed. This phase is essential to clear any remaining microscopic disease. The full chemotherapy course is usually around 14 to 17 cycles in total.
If the cancer has spread at diagnosis
About one in four patients with Ewing sarcoma has metastatic disease at diagnosis. The most common sites are the lungs, other bones and the bone marrow. Treatment for metastatic disease uses the same principles — intensive chemotherapy, local control of the primary tumour, and treatment of the metastatic sites — but is more challenging. For some patients with metastases limited to the lungs, outcomes can still be reasonably good.
What the outlook honestly looks like
Localised Ewing sarcoma
For patients with disease confined to the primary site, treated with the full modern protocol, five-year survival is in the range of 70% to 80%. Outcomes are best for tumours of the arm or leg and for younger patients.
Metastatic Ewing sarcoma
Five-year survival is around 20% to 40%, with a wide range depending on the pattern of spread. Patients with lung-only metastases do considerably better than those with bone or marrow involvement.
These are international averages, not predictions for any one person. Tumour size, location, response to chemotherapy and the quality of local control all matter. We will always sit down with you and work through what the realistic range looks like for your particular case.
Life during the treatment year
There is no soft way to say it — the treatment is gruelling. Cycles every two weeks for many months, frequent admissions, nausea, mouth sores, hair loss, low blood counts, infections, fatigue. For a teenager, missing a year of school, sport and friends is its own kind of loss.
What helps is a team that anticipates the problems and treats them aggressively:
- A central line for chemotherapy and blood tests, placed at the start.
- Aggressive anti-sickness regimens from the first cycle.
- Growth factor injections after each cycle to speed recovery of the blood counts.
- A direct phone line for fever — a temperature during chemotherapy is always treated as urgent, never waited out.
- Nutritional support to keep weight and strength up through the toughest weeks.
- Physiotherapy early and continued through and after local treatment.
- Mental health and family support as a routine part of care, not an afterthought.
- School and university liaison so learning continues where possible, with a planned return after treatment.
Fertility — please raise it on day one
The chemotherapy used in Ewing sarcoma — particularly cyclophosphamide and ifosfamide — can affect future fertility. For boys old enough, sperm banking before chemotherapy is straightforward and important. For girls, options exist but need to be arranged urgently with a fertility specialist before treatment begins. Please bring up this conversation on the very first visit; once chemotherapy has started, the window narrows quickly.
After treatment — survivorship
The end of chemotherapy is the start of a new chapter. Follow-up is intensive in the first two to three years (the period of highest recurrence risk) and continues for many years afterwards. It includes physical examination, MRI of the primary site, CT scans of the chest, and attention to long-term effects of treatment.
Survivorship care for Ewing sarcoma pays attention to heart function (because of doxorubicin), kidney function (because of ifosfamide), hearing, fertility, bone health, the function of the operated limb, and mental health. The aim is not just survival, but the fullest possible life afterwards. Read about survivorship care →
Related services
- Overview of sarcomas
- Osteosarcoma
- Chondrosarcoma
- Chemotherapy
- Radiation therapy
- Multidisciplinary care
- Second opinion
A possible Ewing sarcoma diagnosis? Come in early — and bring everything.
X-rays, MRIs, biopsy reports, molecular test results. We will go through all of it with you, explain what is known and what still needs to be confirmed, and help you plan the next correct step. No rush, no jargon, no false promises — and no false despair either.
Medically reviewed by
Dr. Rehan Abdullah
Dr. Rehan Abdullah is a dual-trained clinical and radiation oncologist with over a decade of experience treating both solid tumours and hematologic malignancies. He serves as Consultant Oncologist at INMOL Hospital and sees patients at Farooq Hospital and Healthnox Medical Center, Lahore. Read full profile →
This page is patient education, not a substitute for an in-person consultation. Cancer care must be individualised. Read our medical disclaimer →